News About: Pharm. Industry
Dong-A’s Management Change Not Likely to Affect Its Stock Price
From a recent announcement surrounding the key management change by Dong-A Pharmaceuticals, the market is viewing this as a positive momentum for the company, reported Kim Hee-sung, an analyst at HanYang Securities.
...
Johnson & Johnson Korea Forms Alliance with Local Wholesaler
Johnson & Johnson Korea announced that the company has made a collaborative alliance agreement with Dongwon Pharmaceuticals, a domestic pharmaceutical wholesale company, to supply Johnson & Johnson’s blood glucose mon...
Redundancy Found in Original Drug Identification Label
The pharmaceutical companies expressed their concerns and difficulties in conforming to an upcoming regulation regarding each company’s original drug identification label requirement effective January 1, 2005.
On...
DMF Implementation Postponed by 8 Months
The Drug Review Division under the Korean Food and Drug Administration (KFDA) announced it will postpone an implementation of the Pharmaceutical Bulk Report System by eight months, suggesting that the Drug Master File...
More Pharmaceutical Companies’ CEOs from R&D, Production Backgrounds
The trend amongst the domestic pharmaceutical companies to promote their production and R&D managers to chief executive officer positions has been observed.
Ever since the separation of dispensary from medical pra...
Serious Side Effects by Isotretinoin Re-Emphasized by KFDA
The Korea Food and Drug Administration (KFDA) re-emphasized on the serious side effects associated with isotretinoin, which is used for treatment of acne, in its December 3rd ‘Dear Healthcare Professional Letter’ addr...
Nationwide Trial of Diovan for Patients Suffering Heart Failure To Be Launched in 2005
Norvatis Korea announced it will launch a nationwide clinical studies of Diovan, an angiotensin receptor blocker (ARB) based anti-hypertension drug, for the treatment of patients suffering heart failure (HF).
The n...
Viagra Tops Domestic ED Market
Viagra showed the largest domestic market share for oral treatments of male erectile dysfunction (ED), according to a recent report released by Pfizer Korea.
The company’s report was based on the market research do...
Innovative Hangover Remedy Introduced to Domestic Market
Giyoung Pharmaceuticals has received an exclusive marketing right for sale and distribution of Korea B.B.K. Plus’s innovative tablet-type hangover remedy, PaliPali.
Korea B.B.K. Plus is a domestic arm of the multin...
Unjust Marketing Activities to Promote OTC Prescriptions
It is found that a certain number of pharmaceutical companies give marketing activities only towards hospitals and clinics for the promotion of OTC products, while neglecting pharmacies, a motive that is thought to in...
